2007-01-30 08:36![[personal profile]](https://www.dreamwidth.org/img/silk/identity/user.png)
digitaldiscipline
digitaldiscipline... and why isn't this the top headline everywhere?
Because the drug, DCA, isn't covered by a patent, which means that is would be "dirt cheap" (the actual phrase used in another article) to produce. Clinical trials will need to be funded by charities, because pharmaceutical companies won't foot the bill for something they won't profit from.
The cool science behind DCA is that it activates the mitochondria in the mutated cancer cells, which makes them die off, instead of being relatively immortal. Money shot image from New Scientist:
How's that for a big whack of good news / bad news?
Further reading and counterpoint: http://scienceblogs.com/insolence/2007/01/in_which_my_words_will_be_misinterpreted.php
Because the drug, DCA, isn't covered by a patent, which means that is would be "dirt cheap" (the actual phrase used in another article) to produce. Clinical trials will need to be funded by charities, because pharmaceutical companies won't foot the bill for something they won't profit from.
The cool science behind DCA is that it activates the mitochondria in the mutated cancer cells, which makes them die off, instead of being relatively immortal. Money shot image from New Scientist:
How's that for a big whack of good news / bad news?
Further reading and counterpoint: http://scienceblogs.com/insolence/2007/01/in_which_my_words_will_be_misinterpreted.php
